EditCell Virology Platform
Summary 1. Identification of host factor, which is required for virus replication, by “EditCell Virology Platform”.2. The host factor will be as a target to develop antivirals.3. The antiviral effects of the candidates can be validated in vitroin vivo.4. Two FDA-approved drugs are repurposed for COVID-19 treatment.
There are still many viruses treat to human, but no effective antivirals against them. The “EditCell Virology Platform” can be used to screen the important factors involved in virus replication,then these factors can serve as targets for antiviral development. Furthermore, we can verify the antiviral effects of the candidates in vitroin vivo to identify effective antivirals against viruses. Based on our previous studies, we have successfully determined two FDA-approved drugs can reduce viral load of SARS-CoV-2. Now, we are seeking collaborations with pharmaceutical company for clinical trials.
The development of antiviral is important for human to fight virus infection,it is also closely related to global economy. Moreover, the rising number of COVID-19 deaths caused by SARS-CoV-2 around the world. COVID-19 pandemics is not only a threat to human lives, but also global economy. Therefore, the researchdevelopment of antivirals are important for application of biomedicalpharmaceutical industriesclinical treatment in the future.
Technical Film
Keyword virus
曾經閱讀此篇文章的人也閱讀過下列文章
Provide the latest information of AI research centers and applied industries
本網站使用您的Cookie於優化網站及您的購物經驗。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。